Filana Therapeutics FLNA
NASDAQ FLNA
$0.81 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Filana Therapeutics (FLNA) EV to EBIT (2010 - 2026)

Filana Therapeutics (FLNA) posted EV to EBIT of 2.68 for Q2 2026, up 507.29% on a QoQ basis from 0.44 in Q1 2026, and up 388.11% year-over-year from 0.55 in Q2 2025.

Analysis

Filana Therapeutics (FLNA) EV to EBIT (2010 - 2026) Analysis & Trends

Filana Therapeutics has reported EV to EBIT for 17 years, with the latest figure at 2.68 in Q2 2026.

  • On a quarterly basis, EV to EBIT rose 388.11% year-over-year to 2.68 in Q2 2026; TTM through Jun 2026 was 0.55, a 185.81% increase from a year earlier, with the FY2025 full-year figure at 0.0, down 101.48% from the prior year.
  • EV to EBIT was 2.68 for Q2 2026 at Filana Therapeutics, up from 0.44 in the prior quarter.
  • The five-year high for EV to EBIT was 2.68 in Q2 2026, with the low at 71.66 in Q1 2022.
  • Average EV to EBIT over 5 years is 24.23, with a median of 24.95 recorded in 2023.
  • The sharpest annual moves came in 2025 and 2026: EV to EBIT slumped 102.17% in 2025, then soared 388.11% in 2026.
  • Over 5 years, EV to EBIT stood at 49.28 in 2022, then grew by 26.13% to 36.4 in 2023, then jumped by 101.38% to 0.5 in 2024, then plunged by 102.17% to 0.01 in 2025, then jumped by 24721.65% to 2.68 in 2026.
  • The last three EV to EBIT figures came in at 2.68 (Q2 2026), 0.44 (Q1 2026), and 0.01 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Filana Therapeutics 38.14 Mn 38.14 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.68
Mar 31, 2026 0.44
Dec 31, 2025 -0.01
Sep 30, 2025 -2.91
Jun 30, 2025 0.55
Mar 31, 2025 1.82
Dec 31, 2024 0.50
Sep 30, 2024 -39.94
Jun 30, 2024 -6.27
Mar 31, 2024 -37.79
Dec 31, 2023 -36.40
Sep 30, 2023 -20.04
Jun 30, 2023 -29.87
Mar 31, 2023 -30.91
Dec 31, 2022 -49.28
Sep 30, 2022 -70.30
Jun 30, 2022 -46.71
Mar 31, 2022 -71.66
Dec 31, 2021 -104.91
Sep 30, 2021 -229.95